Development and deployment of COVID-19 vaccines for those most vulnerable
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and deployment of COVID-19 vaccines for those most vulnerable
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 579, Pages eabd1525
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-02-04
DOI
10.1126/scitranslmed.abd1525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Rational Vaccine Design in the Time of COVID-19
- (2020) Dennis R. Burton et al. Cell Host & Microbe
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
- (2020) Young-Il Kim et al. Cell Host & Microbe
- Vaccine confidence in the time of COVID-19
- (2020) Emily A. Harrison et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The Equitable Distribution of COVID-19 Therapeutics and Vaccines
- (2020) Thomas J. Bollyky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- Covid-19 and Immunity in Aging Populations — A New Research Agenda
- (2020) Wayne C. Koff et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 needs a big science approach
- (2020) Seth Berkley SCIENCE
- U.S. ‘Warp Speed’ vaccine effort comes out of the shadows
- (2020) Jon Cohen SCIENCE
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- A strategic approach to COVID-19 vaccine R&D
- (2020) Lawrence Corey et al. SCIENCE
- The search for a COVID-19 animal model
- (2020) Seema S. Lakdawala et al. SCIENCE
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- The immune response to influenza in older humans: beyond immune senescence
- (2020) Janet E. McElhaney et al. Immunity & Ageing
- Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
- (2020) Wycliffe E. Wei et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- COVID-19 pathophysiology: A review
- (2020) Koichi Yuki et al. CLINICAL IMMUNOLOGY
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
- (2020) Jerome Amir Singh JOURNAL OF INFECTIOUS DISEASES
- Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
- (2020) Yangzi Liu et al. JOURNAL OF MEDICAL ETHICS
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
- (2020) Wei Deng et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
- (2020) John S. Tsang et al. TRENDS IN IMMUNOLOGY
- Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens
- (2020) Jayanthi Wolf et al. npj Vaccines
- COVID‐19 is an emergent disease of aging
- (2020) Didac Santesmasses et al. AGING CELL
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- COVID-19 vaccines: how to ensure Africa has access
- (2020) John N. Nkengasong et al. NATURE
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- Evolution of the COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 in Africa: Dampening the storm?
- (2020) Moustapha Mbow et al. SCIENCE
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- Understanding COVID-19 vaccine efficacy
- (2020) Marc Lipsitch et al. SCIENCE
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
- (2020) Sandhya Bangaru et al. SCIENCE
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Prospects for a safe COVID-19 vaccine
- (2020) Barton F. Haynes et al. Science Translational Medicine
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Covid-19 vaccine trial protocols released
- (2020) Peter Doshi BMJ-British Medical Journal
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
- (2020) Drew Weissman et al. Cell Host & Microbe
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19
- (2020) Jon Cohen SCIENCE
- Vaccines and global health: In search of a sustainable model for vaccine development and delivery
- (2019) Rino Rappuoli et al. Science Translational Medicine
- The future of vaccine development
- (2019) Wayne C. Koff et al. VACCINE
- The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships
- (2019) Joseph S. Bresee et al. VACCINE
- Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
- (2018) Jason K. H. Lee et al. Expert Review of Vaccines
- Causes of impaired oral vaccine efficacy in developing countries
- (2018) Edward PK Parker et al. Future Microbiology
- TORC1 inhibition enhances immune function and reduces infections in the elderly
- (2018) Joan B. Mannick et al. Science Translational Medicine
- Vaccines for the elderly: current use and future challenges
- (2018) Birgit Weinberger Immunity & Ageing
- Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
- (2018) Godfrey A. Dzhivhuho et al. PLoS Pathogens
- The complexity and cost of vaccine manufacturing – An overview
- (2017) Stanley Plotkin et al. VACCINE
- Personalized vaccinology: A review
- (2017) G.A. Poland et al. VACCINE
- Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge
- (2016) Sinthujan Jegaskanda et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosenescence: Implications for response to infection and vaccination in older people
- (2015) Alejandra Pera et al. MATURITAS
- Biological challenges to effective vaccines in the developing world
- (2015) N. C. Grassly et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity
- (2015) Galit Alter et al. VACCINE
- Animal models for SARS and MERS coronaviruses
- (2015) Lisa M Gretebeck et al. Current Opinion in Virology
- Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
- (2014) Enoch Muyanja et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
- (2013) Michael E Pichichero Human Vaccines & Immunotherapeutics
- Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza
- (2013) Laura Matrajt et al. PLoS Computational Biology
- Differential Pathological and Immune Responses in Newly Weaned Ferrets Are Associated with a Mild Clinical Outcome of Pandemic 2009 H1N1 Infection
- (2012) S. S. H. Huang et al. JOURNAL OF VIROLOGY
- Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease
- (2011) M. Frieman et al. JOURNAL OF VIROLOGY
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1
- (2010) David P. Fidler PLOS MEDICINE
- Poverty, Wealth, and Access to Pandemic Influenza Vaccines
- (2009) Tadataka Yamada NEW ENGLAND JOURNAL OF MEDICINE
- Biology of Immune Responses to Vaccines in Elderly Persons
- (2008) Birgit Weinberger et al. CLINICAL INFECTIOUS DISEASES
- An immunosuppressed Syrian golden hamster model for SARS-CoV infection
- (2008) Scott R. Schaecher et al. VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started